Form 4 for PG Procter & Gamble
Accepted 2025-04-30 00:00:00 ET · period of report 2025-04-29 · accession 0001127602-25-012786 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-30 | 2025-04-29 | PG | Davis Jennifer L. | CEO - Health Care | S - Sale | $161.38 | -1,000 | 52.0K | -2% | -$161.4K |
| D | 2025-04-30 | 2025-02-18 | PG | Davis Jennifer L. | CEO - Health Care | A - Grant | $0.00 | +22.16 | 179.89 | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-29 | S | D | 1,000 | $161.38 | 51,964.92 | D | — | — | (F1) Weighted average price of the shares sold. The price range was $161.38 to $161.40. Full information regarding the number of shares sold at each separate price available upon request. (F2) Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. |
| 2 | Derivative | Restricted Stock Units | 2025-02-18 | A | A | 22.16 | $0.00 | 179.89 | D | — · — to — | 22.16 Common Stock | (F4) Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. (F5) These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. |